Advanced Prostate Cancer
The ICHOM Standard Set for Advanced Prostate Cancer is the result of hard work by a group of leading physicians, measurement experts and patients. It is our recommendation of the outcomes that matter most to patients with Advanced Prostate Cancer. We urge all providers around the world to start measuring these outcomes to better understand how to improve the lives of their patients.
- Recorded via the Common Terminology Criteria for Adverse Events (CTCAE), version 4.0
- Recorded via the Eastern Cooperative Oncology Group (ECOG) score
- Includes pain-related quality of life and need for pain medication
- Includes urinary incontinence, urinary frequency, urinary obstruction, urinary irritation, and bowel irritation
- Includes hormonal symptoms
- Recommended to track via the European Organization for Research and Treatment of Cancer Quality of Life Questionnaire (EORTC QLQ-C30)
- Recommended to track via the Expanded Prostate Cancer Index Composite (EPIC-26)
- Includes symptomatic skeletal related event, time to metastasis, castration resistant disease, and procedures needed for local progression
Team that developed this standard
